Stroman David W. 4
4 · NovaBay Pharmaceuticals, Inc. · Filed Oct 6, 2011
Insider Transaction Report
Form 4
Stroman David W.
SVP, Ophthalmic Product Devt.
Transactions
- Award
Option (Right to buy)
2011-10-04$0.86/sh+200,000$172,000→ 0 totalExercise: $0.86From: 2011-10-04Exp: 2021-10-03→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]Granted pursuant to the NovaBay Pharmaceuticals, Inc. 2007 Omnibus Incentive Plan.
- [F2]Ten percent (10%) of the option shares vests and exercisable on the date of the grant and the balance of the option shares vest and become exercisable in a series of five (5) installments upon the completion of the following milestones: 18% upon initiation of the Company's Phase 2b conjunctivitis trial; 18% upon the completion of the Company's Phase 2b conjunctivitis trial; 18% upon the initiation of the Company's Phase 3 conjunctivitis trial;18% upon completion of the Company's Phase 3 conjunctivitis trial and 18% upon execution of a collaboration agreement on the Company's Ophthalmic indication.